Ladenburg Thalmann Financial Services’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$6K Sell
500
-500
-50% -$5.64K ﹤0.01% 4687
2019
Q3
$10K Sell
1,000
-21
-2% -$207 ﹤0.01% 4385
2019
Q2
$9K Hold
1,021
﹤0.01% 4476
2019
Q1
$7K Sell
1,021
-111
-10% -$951 ﹤0.01% 4513
2018
Q4
$8K Buy
1,132
+21
+2% +$176 ﹤0.01% 4384
2018
Q3
$10K Buy
1,111
+111
+11% +$1.13K ﹤0.01% 4271
2018
Q2
$11K Hold
1,000
﹤0.01% 4176
2018
Q1
$11K Hold
1,000
﹤0.01% 4176
2017
Q4
$13K Hold
1,000
﹤0.01% 4031
2017
Q3
$14K Buy
+1,000
New +$12.5K ﹤0.01% 3878
2014
Q1
Sell
-1,200
Closed -$12K 3757
2013
Q4
$12K Buy
+1,200
New +$8.32K ﹤0.01% 2823

Other funds holding CCRN

Ladenburg Thalmann Financial Services's CCRN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Cross Country Healthcare (CCRN) stake by 50% in Q4 2019, selling an estimated $5.64K and leaving 500 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4687.

Ladenburg Thalmann Financial Services first reported a position in CCRN in Q4 2013 and has held it in 11 quarters since. The position peaked at $14K in Q3 2017. 137 funds tracked by Wall St. Rank hold CCRN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 500 shares of Cross Country Healthcare worth $6K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 500 Cross Country Healthcare shares in Q4 2019, an estimated $5.64K.
  • Cross Country Healthcare made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4687 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Cross Country Healthcare in Q4 2013 and has held it in 11 quarters since.
  • Ladenburg Thalmann Financial Services's Cross Country Healthcare position peaked at $14K in Q3 2017.
  • 137 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.